Petmed Express (NASDAQ:PETS) Downgraded by ValuEngine to Sell

Petmed Express (NASDAQ:PETS) was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Monday, February 4th.

Other analysts have also issued reports about the stock. TheStreet lowered shares of Petmed Express from a “b” rating to a “c+” rating in a research report on Thursday, November 29th. BidaskClub raised shares of Petmed Express from a “sell” rating to a “hold” rating in a research report on Wednesday, January 16th. Finally, Craig Hallum decreased their price objective on shares of Petmed Express from $25.00 to $18.00 and set a “sell” rating on the stock in a report on Wednesday, January 23rd. Three research analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. Petmed Express presently has an average rating of “Sell” and a consensus target price of $28.00.

Shares of PETS stock opened at $23.38 on Monday. The firm has a market capitalization of $472.61 million, a PE ratio of 11.32 and a beta of 0.55. Petmed Express has a 12 month low of $20.25 and a 12 month high of $48.32.

Petmed Express (NASDAQ:PETS) last announced its quarterly earnings data on Tuesday, January 22nd. The company reported $0.38 EPS for the quarter, missing the Zacks’ consensus estimate of $0.48 by ($0.10). Petmed Express had a return on equity of 32.89% and a net margin of 14.43%. The business had revenue of $60.10 million during the quarter, compared to the consensus estimate of $64.22 million. During the same period in the prior year, the firm earned $0.44 EPS. The business’s revenue for the quarter was up .0% compared to the same quarter last year.

Large investors have recently added to or reduced their stakes in the business. Capital Investment Advisory Services LLC acquired a new position in shares of Petmed Express in the fourth quarter valued at $26,000. Quantamental Technologies LLC acquired a new position in shares of Petmed Express in the fourth quarter valued at about $71,000. Advisory Services Network LLC grew its stake in shares of Petmed Express by 39.3% in the fourth quarter. Advisory Services Network LLC now owns 3,543 shares of the company’s stock valued at $82,000 after acquiring an additional 1,000 shares in the last quarter. Public Employees Retirement Association of Colorado grew its stake in shares of Petmed Express by 265.5% in the third quarter. Public Employees Retirement Association of Colorado now owns 3,922 shares of the company’s stock valued at $129,000 after acquiring an additional 2,849 shares in the last quarter. Finally, Schroder Investment Management Group acquired a new position in shares of Petmed Express in the second quarter valued at about $214,000. Hedge funds and other institutional investors own 95.04% of the company’s stock.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Article: Is the Dow Jones Industrial Average (DJIA) still relevant?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.